Assam: Yaba Tablets Worth Rs 10 Crore Seized, Five Arrested

Guwahati:  Yaba tablets worth Rs 10 crore have been seized and five people arrested in Assam’s Cachar district on Monday, police said.

Acting on a tip-off, a joint search operation was conducted by the police and the BSF along the Assam-Mizoram inter-state boundary in Chalchapra area and a vehicle was seized, a police officer said.

During the search of the vehicle, several boxes containing Yaba tablets were seized.

Security persons apprehended five persons travelling in the vehicle, and further investigation is underway, he added.

Yaba is illegal in the country because it contains methamphetamine, a Schedule II substance under the Controlled Substances Act.

Related Posts

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

Spurious cosmetic packaging factory busted in northwest Delhi

New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

Spurious cosmetic packaging factory busted in northwest Delhi

Spurious cosmetic packaging factory busted in northwest Delhi

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

UP plans US FDA-accredited medical device testing lab

UP plans US FDA-accredited medical device testing lab

Patent rejected for MNC’s cancer drug, generics to follow

Patent rejected for MNC’s cancer drug, generics to follow

Zydus brings world’s first Nivolumab biosimilar to India

Zydus brings world’s first Nivolumab biosimilar to India